A very positive webinar and lots going on. Clearly this is a 12 to 18 month ramp, but the point he made about Heart failure, when approved by FDA, just being able to be switched on because it is already in the integrations that are occurring will be huge because it means a larger reimbursement, instantly. Thats when revenue starts to go exponential. I have just re listened to it again.
I can see a move into the UK specifically because the Labour Government definitely needs to save money. The UK is broke and the health system is broken. The integration part will be the hard part because hospitals operate on diverse IT systems but, this has to be a massive cost saver. In the Q&A he say he will not mention specific countries but that it comes down to how much they are willing to pay for integrations. The Scandi countries could also be a first cab off the rank.
EIQ Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)